Thursday 29 September 2016

Nebivolol Heumann




Nebivolol Heumann may be available in the countries listed below.


Ingredient matches for Nebivolol Heumann



Nebivolol

Nebivolol hydrochloride (a derivative of Nebivolol) is reported as an ingredient of Nebivolol Heumann in the following countries:


  • Germany

International Drug Name Search

Calapol




Calapol may be available in the countries listed below.


Ingredient matches for Calapol



Paracetamol

Paracetamol is reported as an ingredient of Calapol in the following countries:


  • Indonesia

International Drug Name Search

Alfuzosin Mylan




Alfuzosin Mylan may be available in the countries listed below.


Ingredient matches for Alfuzosin Mylan



Alfuzosin

Alfuzosin hydrochloride (a derivative of Alfuzosin) is reported as an ingredient of Alfuzosin Mylan in the following countries:


  • Slovakia

International Drug Name Search

Floxator




Floxator may be available in the countries listed below.


Ingredient matches for Floxator



Levofloxacin

Levofloxacin is reported as an ingredient of Floxator in the following countries:


  • Greece

International Drug Name Search

Rizoramid R




Rizoramid R may be available in the countries listed below.


Ingredient matches for Rizoramid R



Disopyramide

Disopyramide is reported as an ingredient of Rizoramid R in the following countries:


  • Japan

International Drug Name Search

Wednesday 28 September 2016

Nefrix




Nefrix may be available in the countries listed below.


Ingredient matches for Nefrix



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Nefrix in the following countries:


  • Romania

International Drug Name Search

Tri Rx


Generic Name: prenatal multivitamins (PRE nay tal VYE ta mins)

Brand Names: Advance Care Plus, Bright Beginnings, Cavan Folate, Cavan One, Cavan-Heme OB, Cenogen Ultra, CitraNatal Rx, Co Natal FA, Complete Natal DHA, Complete-RF, CompleteNate, Concept OB, Docosavit, Dualvit OB, Duet, Edge OB, Elite OB 400, Femecal OB, Folbecal, Folcaps Care One, Folivan-OB, Foltabs, Gesticare, Icar Prenatal, Icare Prenatal Rx, Inatal Advance, Infanate DHA, Kolnatal DHA, Lactocal-F, Marnatal-F, Maternity, Maxinate, Mission Prenatal, Multi-Nate 30, Multinatal Plus, Nata 29 Prenatal, Natachew, Natafort, Natelle, Neevo, Nestabs, Nexa Select with DHA, Novanatal, NovaStart, O-Cal Prenatal, OB Complete, OB Natal One, Ob-20, Obtrex DHA, OptiNate, Paire OB Plus DHA, PNV Select, PNV-Total, PR Natal 400, Pre-H-Cal, Precare, PreferaOB, Premesis Rx, PrenaCare, PrenaFirst, PrenaPlus, Prenatabs OBN, Prenatabs Rx, Prenatal 1 Plus 1, Prenatal Elite, Prenatal Multivitamins, Prenatal Plus, Prenatal S, Prenatal-U, Prenate Advanced Formula, Prenate DHA, Prenate Elite, Prenavite FC, PreNexa, PreQue 10, Previte Rx, PrimaCare, Pruet DHA, RE OB Plus DHA, Renate, RightStep, Rovin-NV, Se-Care, Se-Natal One, Se-Plete DHA, Se-Tan DHA, Select-OB, Seton ET, Strongstart, Stuart Prenatal with Beta Carotene, Tandem OB, Taron-BC, Tri Rx, TriAdvance, TriCare, Trimesis Rx, Trinate, Triveen-PRx RNF, UltimateCare Advance, Ultra-Natal, Vemavite PRX 2, VeNatal FA, Verotin-BY, Verotin-GR, Vinacal OR, Vinatal Forte, Vinate Advanced (New Formula), Vinate AZ, Vinate Care, Vinate Good Start, Vinate II (New Formula), Vinate III, Vinate One, Vitafol-OB, VitaNatal OB plus DHA, Vitaphil, Vitaphil Aide, Vitaphil Plus DHA, Vitaspire, Viva DHA, Vol-Nate, Vol-Plus, Vol-Tab Rx, Vynatal F.A., Zatean-CH, Zatean-PN


What are Tri Rx (prenatal multivitamins)?

There are many brands and forms of prenatal vitamin available and not all brands are listed on this leaflet.


Prenatal vitamins are a combination of many different vitamins that are normally found in foods and other natural sources.


Prenatal vitamins are used to provide the additional vitamins needed during pregnancy. Minerals may also be contained in prenatal multivitamins.


Prenatal vitamins may also be used for purposes not listed in this medication guide.


What is the most important information I should know about prenatal vitamins?


There are many brands and forms of prenatal vitamin available and not all brands are listed on this leaflet.


Never take more than the recommended dose of a multivitamin. Avoid taking any other multivitamin product within 2 hours before or after you take your prenatal vitamins. Taking similar vitamin products together at the same time can result in a vitamin overdose or serious side effects.

Many multivitamin products also contain minerals such as calcium, iron, magnesium, potassium, and zinc. Minerals (especially taken in large doses) can cause side effects such as tooth staining, increased urination, stomach bleeding, uneven heart rate, confusion, and muscle weakness or limp feeling. Read the label of any multivitamin product you take to make sure you are aware of what it contains.


Seek emergency medical attention if you think you have used too much of this medicine. An overdose of vitamins A, D, E, or K can cause serious or life-threatening side effects and can also harm your unborn baby. Certain minerals contained in a prenatal multivitamin may also cause serious overdose symptoms or harm to the baby if you take too much.

Overdose symptoms may include stomach pain, vomiting, diarrhea, constipation, loss of appetite, hair loss, peeling skin, tingly feeling in or around your mouth, changes in menstrual periods, weight loss, severe headache, muscle or joint pain, severe back pain, blood in your urine, pale skin, and easy bruising or bleeding.


Do not take this medication with milk, other dairy products, calcium supplements, or antacids that contain calcium. Calcium may make it harder for your body to absorb certain ingredients of the multivitamin.

What should I discuss with my healthcare provider before taking prenatal vitamins?


Many vitamins can cause serious or life-threatening side effects if taken in large doses. Do not take more of this medication than directed on the label or prescribed by your doctor.

Before taking prenatal vitamins, tell your doctor about all of your medical conditions.


You may need to continue taking prenatal vitamins if you breast-feed your baby. Ask your doctor about taking this medication while breast-feeding.

How should I take prenatal vitamins?


Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.


Never take more than the recommended dose of prenatal vitamins.

Many multivitamin products also contain minerals such as calcium, iron, magnesium, potassium, and zinc. Minerals (especially taken in large doses) can cause side effects such as tooth staining, increased urination, stomach bleeding, uneven heart rate, confusion, and muscle weakness or limp feeling. Read the label of any multivitamin product you take to make sure you are aware of what it contains.


Take your prenatal vitamin with a full glass of water.

Swallow the regular tablet or capsule whole. Do not break, chew, crush, or open it.


The chewable tablet must be chewed or allowed to dissolve in your mouth before swallowing. You may also allow the chewable tablet to dissolve in drinking water, fruit juice, or infant formula (but not milk or other dairy products). Drink this mixture right away.


Use prenatal vitamins regularly to get the most benefit. Get your prescription refilled before you run out of medicine completely.


Store at room temperature away from moisture and heat. Keep prenatal vitamins in their original container. Storing vitamins in a glass container can ruin the medication.

What happens if I miss a dose?


Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine. An overdose of vitamins A, D, E, or K can cause serious or life-threatening side effects and can also harm your unborn baby. Certain minerals contained in a prenatal multivitamin may also cause serious overdose symptoms or harm to the baby if you take too much.

Overdose symptoms may include stomach pain, vomiting, diarrhea, constipation, loss of appetite, hair loss, peeling skin, tingly feeling in or around your mouth, changes in menstrual periods, weight loss, severe headache, muscle or joint pain, severe back pain, blood in your urine, pale skin, and easy bruising or bleeding.


What should I avoid while taking prenatal vitamins?


Avoid taking any other multivitamin product within 2 hours before or after you take your prenatal vitamins. Taking similar vitamin products together at the same time can result in a vitamin overdose or serious side effects.

Avoid the regular use of salt substitutes in your diet if your multivitamin contains potassium. If you are on a low-salt diet, ask your doctor before taking a vitamin or mineral supplement.


Do not take this medication with milk, other dairy products, calcium supplements, or antacids that contain calcium. Calcium may make it harder for your body to absorb certain ingredients of the prenatal vitamin.

Prenatal vitamins side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

When taken as directed, prenatal vitamins are not expected to cause serious side effects. Less serious side effects may include:



  • upset stomach;




  • headache; or




  • unusual or unpleasant taste in your mouth.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect prenatal vitamins?


Vitamin and mineral supplements can interact with certain medications, or affect how medications work in your body. Before taking a prenatal vitamin, tell your doctor if you also use:



  • diuretics (water pills);




  • heart or blood pressure medications;




  • tretinoin (Vesanoid);




  • isotretinoin (Accutane, Amnesteen, Clavaris, Sotret);




  • trimethoprim and sulfamethoxazole (Cotrim, Bactrim, Gantanol, Gantrisin, Septra, TMP/SMX); or




  • an NSAID (non-steroidal anti-inflammatory drug) such as ibuprofen (Advil, Motrin), naproxen (Aleve, Naprosyn, Naprelan, Treximet), celecoxib (Celebrex), diclofenac (Cataflam, Voltaren), indomethacin (Indocin), meloxicam (Mobic), and others.



This list is not complete and other drugs may interact with prenatal vitamins. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Tri Rx resources


  • Tri Rx Use in Pregnancy & Breastfeeding
  • Tri Rx Drug Interactions
  • 0 Reviews for Tri Rx - Add your own review/rating


  • Cal-Nate MedFacts Consumer Leaflet (Wolters Kluwer)

  • CareNatal DHA MedFacts Consumer Leaflet (Wolters Kluwer)

  • CitraNatal 90 DHA MedFacts Consumer Leaflet (Wolters Kluwer)

  • CitraNatal Assure Prescribing Information (FDA)

  • CitraNatal Harmony Prescribing Information (FDA)

  • Concept DHA Prescribing Information (FDA)

  • Docosavit Prescribing Information (FDA)

  • Duet DHA with Ferrazone MedFacts Consumer Leaflet (Wolters Kluwer)

  • Folbecal MedFacts Consumer Leaflet (Wolters Kluwer)

  • Folcal DHA Prescribing Information (FDA)

  • Folcaps Care One Prescribing Information (FDA)

  • Gesticare DHA Prescribing Information (FDA)

  • Gesticare DHA MedFacts Consumer Leaflet (Wolters Kluwer)

  • Inatal Advance Prescribing Information (FDA)

  • Inatal Ultra Prescribing Information (FDA)

  • Multi-Nate DHA Prescribing Information (FDA)

  • Multi-Nate DHA Extra Prescribing Information (FDA)

  • MultiNatal Plus MedFacts Consumer Leaflet (Wolters Kluwer)

  • Natelle One Prescribing Information (FDA)

  • Neevo Caplets MedFacts Consumer Leaflet (Wolters Kluwer)

  • Neevo DHA MedFacts Consumer Leaflet (Wolters Kluwer)

  • OB Complete 400 MedFacts Consumer Leaflet (Wolters Kluwer)

  • Paire OB Plus DHA Prescribing Information (FDA)

  • PreNexa MedFacts Consumer Leaflet (Wolters Kluwer)

  • PreNexa Prescribing Information (FDA)

  • PreferaOB Prescribing Information (FDA)

  • Prenatal Plus Prescribing Information (FDA)

  • Prenatal Plus Iron Prescribing Information (FDA)

  • Prenate Elite Prescribing Information (FDA)

  • Prenate Elite MedFacts Consumer Leaflet (Wolters Kluwer)

  • Prenate Elite tablets

  • Prenate Essential Prescribing Information (FDA)

  • PrimaCare Advantage MedFacts Consumer Leaflet (Wolters Kluwer)

  • PrimaCare ONE capsules

  • PrimaCare One MedFacts Consumer Leaflet (Wolters Kluwer)

  • Renate DHA Prescribing Information (FDA)

  • Se-Natal 19 Chewable Tablets MedFacts Consumer Leaflet (Wolters Kluwer)

  • Se-Natal 19 Prescribing Information (FDA)

  • Tandem DHA Prescribing Information (FDA)

  • Tandem OB Prescribing Information (FDA)

  • TriAdvance Prescribing Information (FDA)

  • Triveen-One MedFacts Consumer Leaflet (Wolters Kluwer)

  • Triveen-PRx RNF Prescribing Information (FDA)

  • UltimateCare ONE NF Prescribing Information (FDA)

  • Ultra NatalCare MedFacts Consumer Leaflet (Wolters Kluwer)

  • Vinate AZ Prescribing Information (FDA)

  • Vitafol-One MedFacts Consumer Leaflet (Wolters Kluwer)

  • Zatean-CH Prescribing Information (FDA)



Compare Tri Rx with other medications


  • Vitamin/Mineral Supplementation during Pregnancy/Lactation


Where can I get more information?


  • Your pharmacist can provide more information about prenatal vitamins.


Nicardipine Hydrochloride




Ingredient matches for Nicardipine Hydrochloride



Nicardipine

Nicardipine Hydrochloride (BANM, JAN, USAN) is known as Nicardipine in the US.

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
JANJapanese Accepted Name
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Noax uno




Noax uno may be available in the countries listed below.


Ingredient matches for Noax uno



Tramadol

Tramadol is reported as an ingredient of Noax uno in the following countries:


  • Slovenia

Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Noax uno in the following countries:


  • Austria

  • Croatia (Hrvatska)

International Drug Name Search

Naphensyl




Naphensyl may be available in the countries listed below.


Ingredient matches for Naphensyl



Phenylephrine

Phenylephrine hydrochloride (a derivative of Phenylephrine) is reported as an ingredient of Naphensyl in the following countries:


  • South Africa

International Drug Name Search

Nedis




Nedis may be available in the countries listed below.


Ingredient matches for Nedis



Miconazole

Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Nedis in the following countries:


  • Argentina

International Drug Name Search

Ocu-Sul 30


Generic Name: sulfacetamide ophthalmic (SUL fa SEET a mide off THAL mik)

Brand Names: Bleph-10, Ocu-Sul 10, Ocu-Sul 15, Ocu-Sul 30, Sodium Sulamyd, Sulf-10, Sulfac 10%


What is Ocu-Sul 30 (sulfacetamide ophthalmic)?

Sulfacetamide ophthalmic is an antibiotic.


Sulfacetamide ophthalmic is used to treat bacterial infections of the eyes.


Sulfacetamide ophthalmic may also be used for purposes other than those listed in this medication guide.


What is the most important information I should know about Ocu-Sul 30 (sulfacetamide ophthalmic)?


Do not touch the dropper or tube opening to any surface, including your eyes or hands. The dropper or tube opening is sterile. If it becomes contaminated, it could cause an infection in your eye.

Apply light pressure to the inside corner of your eye (near your nose) after each drop to prevent the fluid from draining down your tear ducts.


Who should not use Ocu-Sul 30 (sulfacetamide ophthalmic)?


Do not use sulfacetamide ophthalmic if you have a viral or fungal infection in your eye. It is used to treat infections caused by bacteria only.

Do not use sulfacetamide ophthalmic if you have ever had an allergic reaction to a sulfa-based drug.


It is not known whether sulfacetamide ophthalmic will harm an unborn baby. Do not use sulfacetamide ophthalmic without first talking to your doctor if you are pregnant. It is also not known whether sulfacetamide ophthalmic passes into breast milk. Do not use sulfacetamide ophthalmic without first talking to your doctor if you are breast-feeding a baby.

How should I use Ocu-Sul 30 (sulfacetamide ophthalmic)?


Use sulfacetamide ophthalmic eyedrops or ointment exactly as directed by your doctor. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.


Wash your hands before using your eyedrops or ointment.


To apply the eye drops:



  • Shake the drops gently to be sure the medicine is well mixed. Tilt your head back slightly and pull down on your lower eyelid. Position the dropper above your eye. Look up and away from the dropper. Squeeze out a drop and close your eye. Apply gentle pressure to the inside corner of your eye (near your nose) for about 1 minute to prevent the liquid from draining down your tear duct. If you are using more than one drop in the same eye or drops in both eyes, repeat the process with about 5 minutes between drops.



To apply the ointment:



  • Hold the tube in your hand for a few minutes to warm it up so that the ointment comes out easily. Tilt your head back slightly and pull down gently on your lower eyelid. Apply a thin film of the ointment into your lower eyelid. Close your eye and roll your eyeball around in all directions for 1 to 2 minutes. If you are applying another eye medication, allow at least 10 minutes before the next application.




Do not touch the dropper or tube opening to any surface, including your eyes or hands. The dropper or tube opening is sterile. If it becomes contaminated, it could cause an infection in your eye. Do not use any eyedrop that is discolored or has particles in it. Store sulfacetamide ophthalmic at room temperature away from moisture and heat. Keep the bottle or tube properly capped.

What happens if I miss a dose?


Apply the missed dose as soon as you remember. However, if it is almost time for your next regularly scheduled dose, skip the missed dose and apply the next one as directed. Do not use a double dose of this medication.


What happens if I overdose?


An overdose of this medication is unlikely to occur. If you do suspect an overdose, wash the eye with water and call an emergency room or poison control center near you. If the drops or ointment have been ingested, drink plenty of fluid and call an emergency center for advice.


What should I avoid while using Ocu-Sul 30 (sulfacetamide ophthalmic)?


Do not touch the dropper or tube opening to any surface, including your eyes or hands. The dropper or tube opening is sterile. If it becomes contaminated, it could cause an infection in your eye. Use caution when driving, operating machinery, or performing other hazardous activities. Sulfacetamide ophthalmic may cause blurred vision. If you experience blurred vision, avoid these activities.

If you wear contact lenses, ask your doctor if you should wear them during treatment with sulfacetamide ophthalmic. After applying the medication, wait at least 15 minutes before inserting contact lenses, unless otherwise directed by your doctor.


Do not use other eye drops or medications during treatment with sulfacetamide ophthalmic unless otherwise directed by your doctor.

Ocu-Sul 30 (sulfacetamide ophthalmic) side effects


Serious side effects are not expected with this medication.


Commonly, some eye burning, stinging, irritation, itching, redness, blurred vision, eyelid itching, eyelid swelling, or sensitivity to light may occur.


This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Ocu-Sul 30 (sulfacetamide ophthalmic)?


Do not use this medication with other eyedrops containing nitrates (e.g., silver nitrate).


Do not use other eye drops or medications during treatment with sulfacetamide ophthalmic unless otherwise directed by your doctor.

Drugs other than those listed here may also interact with sulfacetamide ophthalmic. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines.



More Ocu-Sul 30 resources


  • Ocu-Sul 30 Side Effects (in more detail)
  • Ocu-Sul 30 Use in Pregnancy & Breastfeeding
  • Ocu-Sul 30 Drug Interactions
  • Ocu-Sul 30 Support Group
  • 0 Reviews for Ocu-Sul 30 - Add your own review/rating


  • Bleph-10 Drops MedFacts Consumer Leaflet (Wolters Kluwer)

  • Bleph-10 Prescribing Information (FDA)

  • Isopto Cetamide Prescribing Information (FDA)



Compare Ocu-Sul 30 with other medications


  • Conjunctivitis
  • Trachoma


Where can I get more information?


  • Your pharmacist has additional information about sulfacetamide ophthalmic written for health professionals that you may read.

See also: Ocu-Sul 30 side effects (in more detail)


Nebacumab




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J06BC01

CAS registry number (Chemical Abstracts Service)

0138661-01-5

Therapeutic Category

Immunomodulator

Chemical Name

Immunoglobulin M (human monoclonal HA-1A anti-endotoxin), disulfide with human monoclonal HA-1A kappa-chain, pentameric dimer (WHO)

Foreign Names

  • Nebacumabum (Latin)
  • Nebacumab (German)
  • Nebacumab (French)
  • Nebacumab (Spanish)

Generic Names

  • Nebacumab (OS: BAN, USAN)
  • Nébacumab (OS: DCF)
  • Antiendotoxin monoclonal antibody (IS)
  • HA-1A (IS)
  • Septomonab (IS)
  • Xomen-E5 (IS)

Brand Name

  • Centoxin
    Centocor, Luxembourg

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Nedipin




Nedipin may be available in the countries listed below.


Ingredient matches for Nedipin



Nifedipine

Nifedipine is reported as an ingredient of Nedipin in the following countries:


  • Taiwan

International Drug Name Search

Gaosédal Codéine




Gaosédal Codéine may be available in the countries listed below.


Ingredient matches for Gaosédal Codéine



Codeine

Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Gaosédal Codéine in the following countries:


  • France

Paracetamol

Paracetamol is reported as an ingredient of Gaosédal Codéine in the following countries:


  • France

International Drug Name Search

Delapril




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C09AA12

CAS registry number (Chemical Abstracts Service)

0083435-66-9

Chemical Formula

C26-H32-N2-O5

Molecular Weight

452

Therapeutic Categories

Antihypertensive agent

ACE inhibitor

Chemical Name

Ethyl-(S)-2-[[1-(S)-[(carboxymethyl)-2-indanylcarbamoyl]ethyl]amino]-4-phenylbutyrate

Foreign Names

  • Delaprilum (Latin)
  • Delapril (German)
  • Delapril (French)
  • Delapril (Spanish)

Generic Names

  • Delapril Hydrochloride (OS: JAN, USAN)
  • Alindapril hydrochloride (IS)
  • CV 3317 (IS)
  • REV 6000 A (IS)

Brand Names

  • Beniod
    Chiesi, Spain


  • Delaket
    Chiesi, Italy; Chiesi, Latvia


  • Delapride (Delapril and Indapamide)
    Promedica, Italy; Promedica, Tunisia


  • Dinapres (Delapril and Indapamide)
    Master, Italy


  • Trinordiol
    Chiesi, Spain


  • Adecut
    Takeda, Japan


  • Araplit
    Taisho Yakuhin, Japan


  • Cupressin
    Takeda, Philippines; Takeda, Singapore


  • Defolder
    Yoshindo, Japan


  • Delapride (Delapril and Indapamide)
    Torrex Chiesi, Austria


  • Vivace (Delapril and Manidipine)
    Chiesi, Germany

International Drug Name Search

Glossary

ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Omeprazole Delayed-Release Tablets



Pronunciation: oh-MEP-ra-zole
Generic Name: Omeprazole
Brand Name: Generic only. No brands available.


Omeprazole Delayed-Release Tablets are used for:

Treating frequent (2 or more days a week) heartburn. It may also be used for other conditions as determined by your doctor.


Omeprazole Delayed-Release Tablets are a proton pump inhibitor (PPI). It works by decreasing the amount of acid produced in the stomach.


Do NOT use Omeprazole Delayed-Release Tablets if:


  • you are allergic to any ingredient in Omeprazole Delayed-Release Tablets

  • you have black or bloody stools, trouble or pain when swallowing, or you are vomiting blood

  • you are taking dasatinib, certain HIV protease inhibitors (eg, atazanavir, nelfinavir), rifampin, or St. John's wort.

Contact your doctor or health care provider right away if any of these apply to you.



Before using Omeprazole Delayed-Release Tablets:


Some medical conditions may interact with Omeprazole Delayed-Release Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have low blood potassium or magnesium levels, liver problems, or stomach or bowel cancer

  • if you have nausea or vomiting; stomach pain; heartburn with lightheadedness, sweating, or dizziness; chest or shoulder pain with shortness of breath; unusual sweating; pain spreading to the arms, neck, or shoulders; or lightheadedness

  • if you have unexplained weight loss; frequent chest pain; or frequent wheezing, especially along with heartburn

  • if you have had heartburn for more than 3 months

  • if you have osteoporosis (weak bones), a family history of osteoporosis, or other risk factors of osteoporosis (eg, smoking, poor nutrition)

Some MEDICINES MAY INTERACT with Omeprazole Delayed-Release Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Diuretics (eg, furosemide, hydrochlorothiazide) because the risk of low blood magnesium levels may be increased

  • Voriconazole because it may increase the risk of Omeprazole Delayed-Release Tablets's side effects

  • Ginkgo biloba, rifampin, or St. John's wort because they may decrease Omeprazole Delayed-Release Tablets's effectiveness

  • Anticoagulants (eg, warfarin), benzodiazepines (eg, diazepam), cilostazol, cyclosporine, digoxin, disulfiram, phenytoin, saquinavir, or tacrolimus because the risk of their side effects may be increased by Omeprazole Delayed-Release Tablets

  • Ampicillins, azole antifungals (eg, ketoconazole), clopidogrel, HIV protease inhibitors (eg, atazanavir, nelfinavir), iron, mycophenolate, or tyrosine kinase inhibitors (eg, dasatinib, erlotinib) because their effectiveness may be decreased by Omeprazole Delayed-Release Tablets

This may not be a complete list of all interactions that may occur. Ask your health care provider if Omeprazole Delayed-Release Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Omeprazole Delayed-Release Tablets:


Use Omeprazole Delayed-Release Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Omeprazole Delayed-Release Tablets by mouth on an empty stomach before eating breakfast.

  • Take Omeprazole Delayed-Release Tablets with a full glass of water (8 oz/240 mL).

  • Swallow Omeprazole Delayed-Release Tablets whole. Do not break, crush, or chew before swallowing.

  • You may take antacids while you are using Omeprazole Delayed-Release Tablets if you are directed to do so by your doctor.

  • You may take a 14-day course of Omeprazole Delayed-Release Tablets once every 4 months. Do not take Omeprazole Delayed-Release Tablets for longer than 14 days or take more than 1 course every 4 months without first checking with your doctor.

  • If you miss a dose of Omeprazole Delayed-Release Tablets, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Omeprazole Delayed-Release Tablets.



Important safety information:


  • Omeprazole Delayed-Release Tablets may cause drowsiness or dizziness. These effects may be worse if you take it with alcohol or certain medicines. Use Omeprazole Delayed-Release Tablets with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Omeprazole Delayed-Release Tablets may take 1 to 4 days to reach its full effect. Do NOT take more than the recommended dose or use for longer than 14 days without checking with your doctor.

  • Check with your doctor if your heartburn does not get better or if it gets worse. Check with your doctor if you need to take Omeprazole Delayed-Release Tablets for more than 14 days or if you need to take more than 1 course of treatment every 4 months.

  • Contact your doctor if you have any symptoms of a bleeding ulcer, such as black, tarry stools or vomit that looks like coffee grounds, or if you experience throat pain, chest pain, severe stomach pain, or trouble swallowing.

  • Omeprazole Delayed-Release Tablets may increase the risk of hip, wrist, and spine fractures in patients with weak bones (osteoporosis). The risk may be greater if you use Omeprazole Delayed-Release Tablets in high doses, for longer than a year, or if you are over 50 years old. Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor. Contact your doctor if you have any questions about this information.

  • Low blood magnesium levels have been reported rarely in patients taking PPIs for at least 3 months. In most cases, this effect was seen after a year of treatment. If you will be taking Omeprazole Delayed-Release Tablets for a long time, or if you take certain other medicines (eg, digoxin, diuretics), your doctor may perform lab tests to check for low blood magnesium levels. Seek medical attention right away if you experience symptoms of low blood magnesium levels (eg, dizziness; fast or irregular heartbeat; involuntary muscle movements; jitteriness or tremors; muscle aches, cramps, pain, spasms, or weakness; seizures).

  • Check with your doctor to see whether you should take a calcium and vitamin D supplement while you use Omeprazole Delayed-Release Tablets.

  • Omeprazole Delayed-Release Tablets may interfere with certain lab tests. Be sure your doctor and lab personnel know you are taking Omeprazole Delayed-Release Tablets.

  • Omeprazole Delayed-Release Tablets should be used with caution in Asian patients; the risk of side effects may be increased in these patients.

  • Use Omeprazole Delayed-Release Tablets with caution in the ELDERLY; they may be more sensitive to its effects, especially hip, wrist, and spine fractures.

  • Omeprazole Delayed-Release Tablets should not be used in CHILDREN younger than 18 years old without first checking with their doctor; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Omeprazole Delayed-Release Tablets while you are pregnant. Omeprazole Delayed-Release Tablets are found in breast milk. Do not breast-feed while taking Omeprazole Delayed-Release Tablets.


Possible side effects of Omeprazole Delayed-Release Tablets:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Diarrhea; gas; headache; nausea; stomach pain; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); bone pain; chest pain; dark urine; fast, slow, or irregular heartbeat; fever, chills, or sore throat; red, swollen, blistered, or peeling skin; severe diarrhea; severe stomach pain or cramps; swelling of the hands, ankles, or feet; unusual bruising or bleeding; unusual tiredness; vision changes; yellowing of the eyes or skin.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Omeprazole side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; fast heartbeat; flushing; increased sweating; severe headache, drowsiness, or nausea; vomiting.


Proper storage of Omeprazole Delayed-Release Tablets:

Store Omeprazole Delayed-Release Tablets at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Omeprazole Delayed-Release Tablets out of the reach of children and away from pets.


General information:


  • If you have any questions about Omeprazole Delayed-Release Tablets, please talk with your doctor, pharmacist, or other health care provider.

  • Omeprazole Delayed-Release Tablets are to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Omeprazole Delayed-Release Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Omeprazole resources


  • Omeprazole Side Effects (in more detail)
  • Omeprazole Dosage
  • Omeprazole Use in Pregnancy & Breastfeeding
  • Drug Images
  • Omeprazole Drug Interactions
  • Omeprazole Support Group
  • 46 Reviews for Omeprazole - Add your own review/rating


Compare Omeprazole with other medications


  • Barrett's Esophagus
  • Duodenal Ulcer
  • Erosive Esophagitis
  • GERD
  • Helicobacter Pylori Infection
  • Indigestion
  • Multiple Endocrine Adenomas
  • Stomach Ulcer
  • Systemic Mastocytosis
  • Zollinger-Ellison Syndrome

Necon




Ingredient matches for Necon



Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Necon in the following countries:


  • United States

Norethisterone

Norethisterone is reported as an ingredient of Necon in the following countries:


  • United States

International Drug Name Search

NebuPent




In the US, NebuPent (pentamidine systemic) is a member of the following drug classes: inhaled anti-infectives, miscellaneous antibiotics and is used to treat Leishmaniasis, Pneumocystis Pneumonia, Pneumocystis Pneumonia Prophylaxis and Trypanosomiasis.

US matches:

  • Nebupent Solution

  • Nebupent

Ingredient matches for NebuPent



Pentamidine

Pentamidine isetionate (a derivative of Pentamidine) is reported as an ingredient of NebuPent in the following countries:


  • United States

International Drug Name Search

Indager




Indager may be available in the countries listed below.


Ingredient matches for Indager



Meloxicam

Meloxicam is reported as an ingredient of Indager in the following countries:


  • Mexico

International Drug Name Search

Faslodex 250 mg solution for injection.





Faslodex 250 mg solution for injection



fulvestrant




Read all of this leaflet carefully before you start using this medicine.



  • Keep this leaflet. You may need to read it again.

  • If you have any further questions, ask your doctor, nurse or pharmacist.

  • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.

  • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, nurse or pharmacist.




In this leaflet:



  • 1. What Faslodex is and what it is used for.

  • 2. Before you use Faslodex.

  • 3. How to use Faslodex.

  • 4. Possible side effects.

  • 5. How to store Faslodex.

  • 6. Further information.





What Faslodex is and what it is used for



Faslodex contains the active substance fulvestrant, which belongs to the group of estrogen blockers. Estrogens, a type of female sex hormones, can in some cases be involved in the growth of breast cancer.



Faslodex is used to treat advanced or metastatic breast cancer in postmenopausal women.





Before you use Faslodex




Do not use Faslodex



  • if you are allergic (hypersensitive) to fulvestrant or to any of the other ingredients of Faslodex (listed in section 6 ‘What Faslodex contains’)

  • if you are pregnant or breast-feeding

  • if you have severe liver problems.




Take special care with Faslodex



Tell your doctor if any of these apply to you:



  • kidney or liver problems

  • low numbers of platelets (which help blood clotting) or bleeding disorders

  • previous problems with blood clots

  • osteoporosis (loss of bone density)

  • alcoholism.




Using other medicines



Please tell your doctor, nurse or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.



In particular, you should tell your doctor if you are using anticoagulants (medicines to prevent blood clots).





Pregnancy and breast-feeding



You must not use Faslodex if you are pregnant. If you can become pregnant, you should use effective contraception while being treated with Faslodex.



You must not breast-feed while on treatment with Faslodex.





Driving and using machines



Faslodex is not expected to affect your ability to drive or use machines. However, if you feel tired after treatment do not drive or use machines.





Important information about some of the ingredients of Faslodex



This medicinal product contains 10 % w/v ethanol (alcohol), i.e. up to 1000 mg per dose, equivalent to 20 ml beer or 8 ml wine per dose.



Harmful for those suffering from alcoholism.



To be taken into account in pregnant or breast-feeding women, children and high-risk groups such as patients with liver disease, or epilepsy.






How to use Faslodex



The usual dose is 500 mg fulvestrant (two 250 mg/5 ml injections) given once a month with an additional 500 mg dose given 2 weeks after the initial dose.



Your doctor or nurse will give you Faslodex as a slow intramuscular injection, one into each of your buttocks.





Possible side effects



Like all medicines, Faslodex can cause side effects, although not everybody gets them.



  • These side effects may occur with certain frequencies, which are defined as follows:

  • Very common: affects more than 1 user in 10.

  • Common: affects 1 to 10 users in 100.

  • Uncommon: affects 1 to 10 users in 1,000.

  • Rare: affects 1 to 10 users in 10,000.

  • Very rare: affects less than 1 user in 10,000.

  • Not known: frequency cannot be estimated from the available data.


Very common side effects



  • Injection site reactions, such as pain and/or inflammation.

  • Abnormal levels of liver enzymes (in blood tests).

  • Nausea (feeling sick).

  • Weakness, tiredness.




Common side effects



  • Headache.

  • Hot flushes.

  • Vomiting, diarrhoea, or loss of appetite.

  • Rash.

  • Urinary tract infections.

  • Back pain.

  • Thromboembolism (Increased risk of blood clots).

  • Allergic (hypersensitivity) reactions, including swelling of the face, lips, tongue and/or throat.




Uncommon side effects



  • Vaginal bleeding, thick, whitish discharge and candidiasis (infection).



If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, nurse or pharmacist.





How to store Faslodex



Store in a refrigerator (2°C – 8°C)



Keep the pre-filled syringe in the original package, in order to protect from light.



Keep out of the reach and sight of children.



Do not use after the expiry date which is stated on the carton or syringe labels after the abbreviation EXP. The expiry date refers to the last day of that month.



Your health care professional will be responsible for the correct storage, use and disposal of Faslodex.





Further Information




What Faslodex contains



  • The active substance is fulvestrant. Each pre-filled syringe (5 ml) contains 250 mg fulvestrant.

  • The other ingredients are ethanol (96 per cent), benzyl alcohol, benzyl benzoate and castor oil.




What Faslodex looks like and contents of the pack



Faslodex is a clear, colourless to yellow, viscous solution in a pre-filled syringe fitted with a tamper-evident closure, containing 5 ml solution for injection. Two syringes must be administered to receive the 500 mg recommended monthly dose.



Faslodex has 2 pack presentations, either a pack containing 1 glass pre-filled syringe or a pack containing 2 glass pre-filled syringes. Safety needles (BD SafetyGlide) for connection to each barrel are also provided.



Not all pack sizes may be marketed.





Marketing Authorisation Holder




AstraZeneca UK Limited

Alderley Park

Macclesfield

Cheshire

SK10 4TG

United Kingdom





Manufacturer




AstraZeneca UK Limited

Silk Road Business Park

Macclesfield

Cheshire

SK10 2NA

United Kingdom




For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder (see contacts list).




























































United Kingdom

AstraZeneca UK Ltd

Tel:+ 44 (0)1582 836 836




This leaflet was last approved on 9th April 2010.








Sucrate




Sucrate may be available in the countries listed below.


Ingredient matches for Sucrate



Sucralfate

Sucralfate is reported as an ingredient of Sucrate in the following countries:


  • China

  • Italy

  • Thailand

International Drug Name Search

Zemplar



Generic Name: paricalcitol (Oral route)

par-i-KAL-si-tol

Commonly used brand name(s)

In the U.S.


  • Zemplar

Available Dosage Forms:


  • Capsule, Liquid Filled

Therapeutic Class: Antithyroid Agent


Pharmacologic Class: Vitamin D (class)


Uses For Zemplar


Paricalcitol is used to treat and prevent hyperparathyroidism in patients with chronic kidney disease who are on dialysis. Hyperparathyroidism is a condition that is caused when the parathyroid glands located in the neck make too much parathyroid hormone (PTH). This hormone controls the concentrations of calcium and phosphorus in your blood. Paricalcitol helps lower the amount of PTH which lowers the calcium and phosphorus concentrations.


This medicine is available only with your doctor's prescription.


Before Using Zemplar


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of paricalcitol in the pediatric population. Safety and efficacy have not been established.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of paricalcitol in the elderly.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Ketoconazole

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Bone disease or

  • Heart rhythm problems (e.g., arrhythmia) or

  • Hypercalciuria (high calcium in the urine) or

  • Hyperphosphatemia (high phosphate in the blood) or

  • Seizures—Use with caution. May make these conditions worse.

  • Hypercalcemia (high calcium in the blood) or

  • Vitamin D overdose—Should not be used in patients with these conditions.

Proper Use of Zemplar


Take this medicine only as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered.


You may take this medicine with or without food.


Carefully follow your doctor's instructions about any special diet. Do not use vitamin D, phosphate, or calcium supplements, or antacids containing aluminum without asking your doctor.


Your doctor may tell you to limit your dietary intake of phosphate. Foods that are high in phosphate include beans, beer, chocolate, cheese, cola soft drinks, ice cream, milk, nuts, peas, whole grain products, and yogurt.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage forms (capsules):
    • For hyperparathyroidism in patients with chronic kidney disease:
      • Adults—At first, 1 to 2 micrograms (mcg) once a day or 2 to 4 mcg three times a week (taken not more than every other day) as directed by your doctor. Your doctor may adjust your dose as needed.

      • Children—Use and dose must be determined by your doctor.



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using Zemplar


It is very important that your doctor check your progress at regular visits to make sure that this medicine is working properly. Blood and urine tests may be needed to check for unwanted effects.


Do not take other medicines unless they have been discussed with your doctor. Taking other medicines (especially digoxin, Lanoxin®) together with paricalcitol may require your doctor to change the dose of one of the medicines or paricalcitol.


This medicine may increase the calcium in your blood (hypercalcemia). The symptoms of high calcium may include abdominal or stomach pain; confusion; constipation; depression; dry mouth; headache; incoherent speech; increased urination; loss of appetite; metallic taste; muscle weakness; nausea; thirst; unusual tiredness; vomiting; or weight loss. If you have any of these symptoms, check with your doctor immediately.


This medicine may increase the aluminum in your blood and may cause harm to your bones if used in combination with any products containing aluminum (e.g., antacids or phosphate binders). Ask your doctor before you take any of these products.


Zemplar Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Blurred vision

  • cough or hoarseness

  • difficulty with swallowing

  • dizziness

  • fever or chills

  • headache

  • hives

  • itching

  • lower back or side pain

  • nervousness

  • pain

  • painful or difficult urination

  • pounding in the ears

  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue

  • shortness of breath

  • skin rash

  • slow or fast heartbeat

  • swelling

  • tightness in the chest

  • unusual tiredness or weakness

  • wheezing

Less common
  • Abdominal or stomach pain

  • abnormal growth filled with fluid or semisolid material

  • ammonia-like breath odor

  • anxiety

  • bladder pain

  • bloating or swelling of the face, arms, hands, lower legs, or feet

  • bloody or cloudy urine

  • burning, tingling, numbness or pain in the hands, arms, feet, or legs

  • chest pain or discomfort

  • cold sweats

  • coma

  • confusion

  • convulsions

  • cool, pale skin

  • decreased urine

  • depression

  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position

  • drowsiness

  • dry mouth

  • fainting

  • frequent urge to urinate

  • general feeling of discomfort or illness

  • increase in heart rate

  • increased hunger

  • increased thirst

  • irregular heartbeat

  • joint pain

  • lightheadedness

  • loss of appetite

  • muscle aches and pains

  • nausea or vomiting

  • nightmares

  • numbness or tingling in the hands, feet, or lips

  • pain or discomfort in the arms, jaw, back, or neck

  • rapid breathing

  • rapid weight gain

  • runny nose

  • sensation of pins and needles

  • shakiness

  • shivering

  • slurred speech

  • sneezing

  • sore throat

  • stabbing pain

  • sunken eyes

  • sweating

  • thirst

  • trouble sleeping

  • troubled breathing

  • unusual weight gain or loss

  • weight loss

  • wrinkled skin

Incidence not known
  • Large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs

  • slow or irregular breathing

Get emergency help immediately if any of the following symptoms of overdose occur:


Symptoms of overdose
  • Abdominal or stomach cramps

  • constipation

  • depression

  • high urine levels of calcium

  • incoherent speech

  • increased urination

  • metallic taste

  • muscle cramps in the hands, arms, feet, legs, or face

  • muscle weakness

  • tremor

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Less common
  • Acid or sour stomach

  • back pain

  • belching

  • bloody nose

  • bruising

  • change in vision

  • cough producing mucus

  • difficulty with moving

  • feeling of constant movement of self or surroundings

  • heartburn

  • impaired vision

  • indigestion

  • lack or loss of strength

  • large, flat, blue, or purplish patches in the skin

  • leg cramps

  • muscle pain or stiffness

  • pain or tenderness around the eyes and cheekbones

  • pain, swelling, or redness in the joints

  • sensation of spinning

  • sores on the skin

  • stomach discomfort, upset, or pain

  • stuffy nose

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Zemplar side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Zemplar resources


  • Zemplar Side Effects (in more detail)
  • Zemplar Use in Pregnancy & Breastfeeding
  • Drug Images
  • Zemplar Drug Interactions
  • Zemplar Support Group
  • 0 Reviews for Zemplar - Add your own review/rating


  • Zemplar Prescribing Information (FDA)

  • Zemplar Consumer Overview

  • Zemplar Monograph (AHFS DI)

  • Zemplar MedFacts Consumer Leaflet (Wolters Kluwer)

  • Paricalcitol Professional Patient Advice (Wolters Kluwer)



Compare Zemplar with other medications


  • Secondary Hyperparathyroidism

Subheron




Subheron may be available in the countries listed below.


Ingredient matches for Subheron



Ibuprofen

Ibuprofen is reported as an ingredient of Subheron in the following countries:


  • Japan

International Drug Name Search

Sertan




Sertan may be available in the countries listed below.


Ingredient matches for Sertan



Primidone

Primidone is reported as an ingredient of Sertan in the following countries:


  • Hungary

International Drug Name Search

Ethynodiol Diacetate




Ethynodiol Diacetate may be available in the countries listed below.


Ingredient matches for Ethynodiol Diacetate



Etynodiol

Ethynodiol Diacetate (USAN) is also known as Etynodiol (Prop.INN)

International Drug Name Search

Glossary

Prop.INNProposed International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Adrenalin Leciva




Adrenalin Leciva may be available in the countries listed below.


Ingredient matches for Adrenalin Leciva



Epinephrine

Epinephrine hydrochloride (a derivative of Epinephrine) is reported as an ingredient of Adrenalin Leciva in the following countries:


  • Czech Republic

  • Slovakia

International Drug Name Search

Nasomet Singad Pharma




Nasomet Singad Pharma may be available in the countries listed below.


Ingredient matches for Nasomet Singad Pharma



Mometasone

Mometasone 17-(2-furoate) (a derivative of Mometasone) is reported as an ingredient of Nasomet Singad Pharma in the following countries:


  • Denmark

International Drug Name Search

Aquril




Aquril may be available in the countries listed below.


Ingredient matches for Aquril



Quinapril

Quinapril is reported as an ingredient of Aquril in the following countries:


  • Romania

International Drug Name Search

Narfen




Narfen may be available in the countries listed below.


Ingredient matches for Narfen



Ibuprofen

Ibuprofen is reported as an ingredient of Narfen in the following countries:


  • Spain

International Drug Name Search

Contac




Contac may be available in the countries listed below.


UK matches:

  • Contac Non Drowsy 12 Hour Relief (SPC)
  • Contac Non Drowsy Dual Relief Tablets (SPC)

Ingredient matches for Contac



Paracetamol

Paracetamol is reported as an ingredient of Contac in the following countries:


  • Germany

Pseudoephedrine

Pseudoephedrine hydrochloride (a derivative of Pseudoephedrine) is reported as an ingredient of Contac in the following countries:


  • Canada

  • Poland

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Pitoxil




Pitoxil may be available in the countries listed below.


Ingredient matches for Pitoxil



Moxifloxacin

Moxifloxacin is reported as an ingredient of Pitoxil in the following countries:


  • Turkey

International Drug Name Search

Prostazid




Prostazid may be available in the countries listed below.


Ingredient matches for Prostazid



Tamsulosin

Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Prostazid in the following countries:


  • Germany

International Drug Name Search

Urea in Zinc/Lactic Acid Nail Stick


Pronunciation: ue-REE-a/zink/LAK-tik AS-id
Generic Name: Urea in Zinc/Lactic Acid
Brand Name: Urea Nail


Urea in Zinc/Lactic Acid Nail Stick is used for:

Aiding in the healing of certain skin and nail conditions (eg, calluses; corns; dry, rough skin; eczema; psoriasis; ingrown nails). It may also be used for other conditions as determined by your doctor.


Urea in Zinc/Lactic Acid Nail Stick is a debriding agent. It works by helping to loosen, soften, and shed nails or hard and scaly skin.


Do NOT use Urea in Zinc/Lactic Acid Nail Stick if:


  • you are allergic to any ingredient in Urea in Zinc/Lactic Acid Nail Stick

Contact your doctor or health care provider right away if this applies to you.



Before using Urea in Zinc/Lactic Acid Nail Stick:


Some medical conditions may interact with Urea in Zinc/Lactic Acid Nail Stick. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of blood circulation problems or diabetes

Some MEDICINES MAY INTERACT with Urea in Zinc/Lactic Acid Nail Stick. Because little, if any, of Urea in Zinc/Lactic Acid Nail Stick is absorbed into the blood, the risk of it interacting with another medicine is low.


Ask your health care provider if Urea in Zinc/Lactic Acid Nail Stick may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Urea in Zinc/Lactic Acid Nail Stick:


Use Urea in Zinc/Lactic Acid Nail Stick as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Shake well before each use.

  • Apply Urea in Zinc/Lactic Acid Nail Stick to the affected area as directed by your doctor. Gently rub it in until it is evenly distributed.

  • Wash your hands immediately after using Urea in Zinc/Lactic Acid Nail Stick, unless your hands are part of the treated area.

  • As Urea in Zinc/Lactic Acid Nail Stick dries, it may turn white in color. This is normal and not a cause for concern.

  • Use Urea in Zinc/Lactic Acid Nail Stick on a regular schedule to get the most benefit from it.

  • If you miss a dose of Urea in Zinc/Lactic Acid Nail Stick, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Urea in Zinc/Lactic Acid Nail Stick.



Important safety information:


  • Urea in Zinc/Lactic Acid Nail Stick is for external use only. Do not use near the vaginal/groin area. Do not get it on your lips or in your eyes, nose, or mouth. If you get it in any of these areas, rinse right away with cool tap water.

  • Tell your doctor if your condition persists or worsens while using Urea in Zinc/Lactic Acid Nail Stick.

  • Do not use more than the recommended dose or use for longer than prescribed without checking with your doctor.

  • Do not use Urea in Zinc/Lactic Acid Nail Stick for other skin conditions without checking with your doctor.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Urea in Zinc/Lactic Acid Nail Stick while you are pregnant. It is not known if Urea in Zinc/Lactic Acid Nail Stick is found in breast milk after topical use. If you are or will be breast-feeding while you use Urea in Zinc/Lactic Acid Nail Stick, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Urea in Zinc/Lactic Acid Nail Stick:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Mild, temporary burning, stinging, or itching of the skin.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); severe or persistent skin burning, stinging, or itching; skin redness or irritation.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.



If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Urea in Zinc/Lactic Acid Nail Stick:

Store Urea in Zinc/Lactic Acid Nail Stick at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Protect from freezing. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Urea in Zinc/Lactic Acid Nail Stick out of the reach of children and away from pets.


General information:


  • If you have any questions about Urea in Zinc/Lactic Acid Nail Stick, please talk with your doctor, pharmacist, or other health care provider.

  • Urea in Zinc/Lactic Acid Nail Stick is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Urea in Zinc/Lactic Acid Nail Stick. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

Nébacumab




Nébacumab may be available in the countries listed below.


Ingredient matches for Nébacumab



Nebacumab

Nébacumab (DCF) is also known as Nebacumab (Rec.INN)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Metebanyl




Metebanyl may be available in the countries listed below.


Ingredient matches for Metebanyl



Drotebanol

Drotebanol is reported as an ingredient of Metebanyl in the following countries:


  • Japan

International Drug Name Search

Carbamazepine




In some countries, this medicine may only be approved for veterinary use.


In the US, Carbamazepine (carbamazepine systemic) is a member of the drug class dibenzazepine anticonvulsants and is used to treat Bipolar Disorder, Diabetic Nerve Damage, Dystonia, Epilepsy, Peripheral Neuropathy, Reflex Sympathetic Dystrophy Syndrome, Schizoaffective Disorder, Trigeminal Neuralgia and Vulvodynia.

US matches:

  • Carbamazepine

  • Carbamazepine Chewable Tablets

  • Carbamazepine Suspension

  • Carbamazepine Sustained-Release Capsules

  • Carbamazepine Sustained-Release Tablets

  • Carbamazepine Chewable

  • Carbamazepine ER

  • Carbamazepine Oral Suspension

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N03AF01

CAS registry number (Chemical Abstracts Service)

0000298-46-4

Chemical Formula

C15-H12-N2-O

Molecular Weight

236

Therapeutic Category

Antiepileptic agent

Chemical Name

5H-Dibenz[b,f]azepine-5-carboxamide

Foreign Names

  • Carbamazepinum (Latin)
  • Carbamazepin (German)
  • Carbamazépine (French)
  • Carbamazepina (Spanish)

Generic Names

  • Carbamacepina (OS: DCIT)
  • Carbamazepine (OS: USAN, JAN, BAN)
  • Carbamazépine (OS: DCF)
  • G 32 883 (IS)
  • Carbamazepin (PH: Ph. Eur. 6)
  • Carbamazepine (PH: BP 2010, Ph. Eur. 5, Ph. Int. 4, USP 32, JP XV)
  • Carbamazépine (PH: Ph. Eur. 6)
  • Carbamazepinum (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

  • Actebral
    Pharmalab, Peru; Sanofi-Aventis, Ecuador


  • Actinerval
    Bago, Russian Federation; Bagó, Argentina; Bagó, Ecuador


  • Amizepin
    Polpharma, Poland; Polpharma, Vietnam


  • Apo-Carbamazepine
    Apotex, Canada; Apotex, Hong Kong; Apotex, Peru; Apotex, Singapore; Apotex, Vietnam; Apotex Inc., Russian Federation


  • Bamgetol
    Mersifarma, Indonesia


  • Basitrol
    Colliere, Peru


  • Biston
    Zentiva, Czech Republic; Zentiva, Slovakia


  • Brucarcer
    Bruluart, Mexico


  • C.M.P.200
    Klonal, Argentina


  • Cabretol
    Renata, Bangladesh


  • Carbabeta
    Betapharm, Germany


  • Carba-CT
    CT Arzneimittel, Germany


  • Carbadura
    Mylan dura, Germany


  • Carbaflux
    Hennig, Germany


  • Carbagamma
    Wörwag Pharma, Germany


  • Carbagramon
    Gramon, Argentina


  • Carbalex
    Gerot, Estonia; Gerot, Lithuania; Gerot, Latvia


  • Carbaltpsin
    Akrihin, Russian Federation


  • Carbamat
    Pfizer, Argentina


  • Carbamazepin Actavis
    Actavis, Lithuania; Actavis, Netherlands; Balkanpharma, Bulgaria


  • Carbamazepin AL
    Aliud, Germany


  • Carbamazepin Aristo
    Aristo Pharma, Germany


  • Carbamazepin EEL
    Bio EEL, Romania


  • Carbamazepin Heumann
    Heumann, Germany


  • Carbamazepin Hexal
    Hexal, Germany; Hexal, Luxembourg


  • Carbamazepin Nycomed
    Nycomed, Estonia


  • Carbamazepin ratiopharm
    ratiopharm, Netherlands


  • Carbamazepin Sandoz
    Sandoz, Germany


  • Carbamazepin Stada
    Stada, Germany


  • Carbamazepin
    Actavis, Georgia; GAMA, Georgia; GMP, Georgia; Medopharm, Georgia; Slavia Pharm, Romania


  • Carbamazepin-1A Pharma
    1A Pharma, Germany


  • Carbamazepina AG
    American Generics, Peru


  • Carbamazepina Alter
    Alter, Spain; Alter, Portugal


  • Carbamazepina Best
    Best, Colombia


  • Carbamazepina Denver Farma
    Denver, Argentina


  • Carbamazepina EG
    EG, Italy


  • Carbamazepina Fabra
    Fabra, Argentina


  • Carbamazepina Farmabion
    Farmalter, Spain


  • Carbamazepina Generis
    Generis, Portugal


  • Carbamazepina Genfar
    Genfar, Colombia; Genfar, Ecuador


  • Carbamazepina L.CH.
    Chile, Chile


  • Carbamazepina La Santé
    La Santé, Colombia


  • Carbamazepina Labesfal
    Labesfal, Portugal


  • Carbamazepina LPH
    Labormed Pharma, Georgia; Labormed Pharma, Romania


  • Carbamazepina Merck
    Merck Genéricos, Portugal


  • Carbamazepina MF
    Marfan, Peru


  • Carbamazepina MK
    MK, Colombia


  • Carbamazepina Normon
    Normon, Costa Rica; Normon, Dominican Republic; Normon, Spain; Normon, Guatemala; Normon, Honduras; Normon, Nicaragua; Normon, Panama; Normon, El Salvador


  • Carbamazepina Perugen
    Perugen, Peru


  • Carbamazepina Teva
    Teva, Italy; Teva, Romania


  • Carbamazepina
    Arena, Romania; Astral, Peru; Bestpharma, Chile; Bouzen, Argentina; Drintefa, Peru; Ecuaquímica, Ecuador; Elter - Medicamentos Genéricos, Venezuela; Flupal, Venezuela; G&R, Peru; Genéricos Venezolanos, Venezuela; Induquimica, Peru; Infarmasa, Peru; Labot, Peru; Laropharm, Romania; Medicalex, Colombia; Mintlab, Chile; OFA, Venezuela; Ozone Laboratories, Romania; Pasteur, Chile; Sanitas, Chile


  • Carbamazepin-biomo
    Biomo, Germany


  • Carbamazepine A
    Apothecon, Netherlands


  • Carbamazepine CF
    Centrafarm, Netherlands


  • Carbamazepine Katwijk
    Apotex Europe, Netherlands


  • Carbamazepine Merck
    Mylan, Netherlands


  • Carbamazépine Mylan LP
    Mylan, France


  • Carbamazepine Mylan
    Mylan, Belgium


  • Carbamazepine PCH
    Pharmachemie, Netherlands


  • Carbamazépine Sandoz L.P.
    Sandoz, France


  • Carbamazepine Sandoz
    Sandoz, Australia; Sandoz, Netherlands


  • Carbamazepine Teva
    Teva, Latvia


  • Carbamazépine Teva
    Teva Santé, France


  • Carbamazepine
    Actavis, United States; Apotex, United States; Cadista, United States; Canonpharma, Russian Federation; Inwood, United States; Morton Grove, United States; Nycomed, Georgia; Taro, United States; Teva USA, United States; Torrent, United States


  • Carbamazepine-Akri
    Akrihin, Russian Federation


  • Carbamazepin-neuraxpharm
    Neuraxpharm, Germany


  • Carbamazepin-ratiopharm
    Ratiopharm, Germany


  • Carbamazepin-Teva
    Teva, Germany


  • Carbapin
    Medifarma, Peru


  • Carbatol
    Dar-Al-Dawa, United Arab Emirates; Dar-Al-Dawa, Bahrain; Dar-Al-Dawa, Iraq; Dar-Al-Dawa, Jordan; Dar-Al-Dawa, Kuwait; Dar-Al-Dawa, Lebanon; Dar-Al-Dawa, Libya; Dar-Al-Dawa, Nigeria; Dar-Al-Dawa, Qatar; Dar-Al-Dawa, Saudi Arabia; Dar-Al-Dawa, Sudan; Dar-Al-Dawa, Somalia; Dar-Al-Dawa, Tunisia; Dar-Al-Dawa, Yemen; Torrent, India; Torrent, Lithuania; Torrent, Vietnam; Torrent Pharmaceuticals, Ethiopia


  • Carbatrol
    Iqfarma, Peru; Shire, United States


  • Carbavim
    VIM Spectrum, Romania


  • Carbazin
    Eskayef, Bangladesh


  • Carbazina
    Psicofarma, Mexico


  • Carbazine
    United Pharmaceutical, United Arab Emirates; United Pharmaceutical, Bahrain; United Pharmaceutical, Iraq; United Pharmaceutical, Jordan; United Pharmaceutical, Libya; United Pharmaceutical, Qatar; United Pharmaceutical, Saudi Arabia; United Pharmaceutical, Sudan; United Pharmaceutical, Yemen


  • Carbepsil
    Helcor, Romania


  • Carbium
    Hexal, Luxembourg


  • Carmapine
    Pei Li, Taiwan


  • Carmaz
    Aristopharma, Bangladesh


  • Carpin
    Novag, Mexico


  • Carpine
    Taiwan Biotech, Taiwan


  • Carsol
    Sandoz, Switzerland


  • Carzepin
    Hovid, Hong Kong; Unifarm, Peru


  • Cazerol
    PMP, Vietnam


  • Cepilep
    ACI, Bangladesh


  • Conformal
    Ivax, Argentina


  • Convulex Meyer
    Meyer, Venezuela


  • CP-Carba
    Christo Pharmaceutical, Hong Kong


  • Degranol
    Aspen Pharmacare, South Africa


  • Deleptin
    Stada, Austria


  • Epilep
    Beximco, Bangladesh


  • Epilepsin
    Macter, Myanmar


  • Epitol
    Teva USA, United States


  • Eposal
    La Santé, Venezuela; Novamed, Colombia; Sanofi-Aventis, Chile


  • Equetro
    Shire, United States


  • espa-lepsin
    Esparma, Germany


  • Finlepsin
    Arzneimittelwerk Dresden, Poland; AWD, Bulgaria; AWD Pharma, Estonia; AWD Pharma, Georgia; AWD Pharma, Romania; AWD.pharma, Germany; AWD.pharma, Lithuania; AWD.pharma, Latvia; Pliva, Russian Federation


  • Fitzecalm
    Julphar, Bahrain; Julphar, Oman


  • Galepsin
    Galenika, Serbia


  • Gamalepshin
    GAMA, Georgia


  • Gen-Carbamazepine CR
    Genpharm, Canada


  • Gericarb
    Gerard, Ireland


  • Hermolepsin
    Orion, Sweden


  • Hermolepsin Retard
    Orion, Sweden


  • Karazepin
    Terra, Turkey


  • Karbalex
    Liba, Turkey


  • Karbamazepin Dak
    Nycomed, Denmark


  • Karbamazepin NM Pharma
    Gerard, Iceland


  • Karbamazepin Nycomed
    Nycomed, Latvia


  • Karbamazepin
    Mylan, Norway


  • Karbapin
    Hemofarm, Serbia


  • Karbasif
    Yeni, Turkey


  • Karberol
    Münir Sahin, Turkey


  • Kazepin
    Günsa, Turkey


  • Lepsitol
    Metiska, Indonesia


  • Lexin
    Fujinaga Seiyaku, Japan


  • Mazetol
    Sarabhai, India


  • Melepsin
    World Medicine, Georgia


  • Neugeron
    Armstrong, Mexico


  • Neurotol
    Orion, Finland; Orion, Taiwan


  • Neurotop retard
    Gerot, Austria; Gerot, Czech Republic


  • Neurotop
    Gerot, Austria; Gerot, Czech Republic; Gerot, Hungary; Gerot, Poland; Gerot, Romania; Gerot, Singapore; Gerot, Slovakia; Orion, Switzerland


  • PMS-Carbamazepine
    Pharmascience, Canada


  • Sandoz Carbamazepine
    Sandoz, Canada; Sandoz, South Africa


  • Stazepine
    Adipharm, Bulgaria; Polpharma, Bulgaria; Polpharma, Hungary; Polpharma, Romania


  • Storilat
    Remedica, Cyprus; Remedica, Oman


  • Tanfedin
    Roemmers, Venezuela


  • Taro-Carbamazepine
    Taro, Canada


  • Taver
    Medochemie, Romania; Medochemie, Tunisia; Medochemie, Vietnam


  • Tegol
    Yu Sheng, Taiwan


  • Tegral
    Chemical Industries, Ethiopia


  • Tegrebos
    Bosnalijek, Bosnia & Herzegowina


  • Tegretal
    Novartis, Chile; Novartis, Germany; Novartis, Luxembourg


  • Tegretard
    Cristália, Brazil


  • Tegretol Retard Lyfjaver
    Lyfjaver, Iceland


  • Tegretol
    Euro, Netherlands; Novartis, Argentina; Novartis, Austria; Novartis, Australia; Novartis, Bangladesh; Novartis, Belgium; Novartis, Bulgaria; Novartis, Brazil; Novartis, Canada; Novartis, Switzerland; Novartis, China; Novartis, Colombia; Novartis, Czech Republic; Novartis, Denmark; Novartis, Algeria; Novartis, Ecuador; Novartis, Estonia; Novartis, Spain; Novartis, Ethiopia; Novartis, Finland; Novartis, United Kingdom; Novartis, Georgia; Novartis, Ghana; Novartis, Greece; Novartis, Guyana; Novartis, Hong Kong; Novartis, Hungary; Novartis, Indonesia; Novartis, Ireland; Novartis, Israel; Novartis, India; Novartis, Iceland; Novartis, Italy; Novartis, Japan; Novartis, Kenya; Novartis, Sri Lanka; Novartis, Lithuania; Novartis, Luxembourg; Novartis, Latvia; Novartis, Libya; Novartis, Malta; Novartis, Mexico; Novartis, Malaysia; Novartis, Nigeria; Novartis, Netherlands; Novartis, Norway; Novartis, New Zealand; Novartis, Oman; Novartis, Philippines; Novartis, Poland; Novartis, Portugal; Novartis, Romania; Novartis, Serbia; Novartis, Russian Federation; Novartis, Sudan; Novartis, Sweden; Novartis, Singapore; Novartis, Slovakia; Novartis, Thailand; Novartis, Tunisia; Novartis, Turkey; Novartis, Taiwan; Novartis, Tanzania; Novartis, United States; Novartis, Venezuela; Novartis, Vietnam; Novartis, South Africa; Novartis, Zimbabwe; Novartis Pharmaceuticals, Peru; Pliva, Bosnia & Herzegowina; Pliva, Croatia (Hrvatska); Pliva, Slovenia


  • Tégrétol
    Novartis, Burkina Faso; Novartis, Benin; Novartis, Congo; Novartis, Cote D'ivoire; Novartis, Cameroon; Novartis, France; Novartis, Gabon; Novartis, Guinea; Novartis, Madagascar; Novartis, Mali; Novartis, Mauritius; Novartis, Niger; Novartis, Senegal; Novartis, Togo; Novartis, Zaire


  • Tegretol (veterinary use)
    Cephalon, United Kingdom


  • Tegretol Retard
    Eurim, Austria; Novartis, Austria; Novartis, Iceland; Novartis, Norway; Novartis, Sweden


  • Tegrital
    Novartis, India


  • Telesmin
    Tanabe Mitsubishi, Japan


  • Temporol
    Orion, United Arab Emirates; Orion, Bahrain; Orion, Egypt; Orion, Jordan; Orion, Kuwait; Orion, Lebanon


  • Teril
    Alphapharm, Australia; Alphapharm, Taiwan; Eczacibasi, Turkey; Merck Marker, Myanmar; Taro, Israel; Taro, United States


  • Ternal
    Fluter, Dominican Republic


  • Timonil
    Desitin, Switzerland; Desitin, Czech Republic; Desitin, Germany; Desitin, Estonia; Desitin, Israel; Desitin, Poland; Desitin, Romania; Desitin Pharma, Slovakia


  • Trimonil Retard
    Desitin, Denmark; Desitin, Norway; Desitin, Sweden


  • Vulsivan
    Psipharma, Colombia


  • Zeptol
    Sun, Bangladesh; Sun, Myanmar; Sun, Russian Federation

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.